Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Yang, Wei  [Clear All Filters]
2023
Li Y, Yang W, Wang HC, Patel RM, Casey EB, Denby ED, Magee JA. Basal type I interferon signaling has only modest effects on neonatal and juvenile hematopoiesis. Blood Adv. 2023.
Ma N, Zhao S, Yang W, Wang Y. B-cell-specific Moloney murine leukemia virus integration site 1 knockdown impairs adriamycin resistance of gastric cancer cells. Arab J Gastroenterol. 2023.
Chen W, Wang Y, Zheng J, Chen Y, Zhang C, Yang W, Wu L, Yang Z, Wang Y, Shi C. Characterization of cellular senescence in radiation ulcers and therapeutic effects of mesenchymal stem cell-derived conditioned medium. Burns Trauma. 2023;11:tkad001.
Yuan X, Yang W, Fu Y, Tao Z, Xiao L, Zheng Q, Wu D, Zhang M, Li L, Lu Z, et al. Four-arm Polymer-Guided Formation of Curcumin-Loaded Flower-Like Porous Microspheres As Injectable Cell Carriers For Diabetic Wound Healing. Adv Healthc Mater. 2023:e2301486.
Zhang Z-M, Yu P, Zhou K, Yu F-Y, Bao R-Y, Yang M-Bo, Qian Z-Y, Yang W. Hierarchically Porous Implants Orchestrating a Physiological Viscoelastic and Piezoelectric Microenvironment for Bone Regeneration. Adv Healthc Mater. 2023:e2300713.
Yang S, Zhang X, Gale RPeter, Du X, Chen C-Y, Weng J-Y, Huang J, Li F, Zeng Y, Xiao Z, et al. Imatinib compared with second-generation tyrosine kinase-inhibitors in persons with chronic myeloid leukemia presenting in accelerated phase. Am J Hematol. 2023.
Sun L, Yang N, Chen B, Bei Y, Kang Z, Zhang C, Zhang N, Xu P, Yang W, Wei J, et al. A novel mesenchymal stem cell-based regimen for acute myeloid leukemia differentiation therapy. Acta Pharm Sin B. 2023;13(7):3027-3042.
Bai X, Chen T, Li Y, Ge X, Qiu C, Gou H, Wei S, Liu T, Yang W, Yang L, et al. PD-L1 expression levels in mesenchymal stromal cells predict their therapeutic values for autoimmune hepatitis. Stem Cell Res Ther. 2023;14(1):370.
Ruan B, Zhu Z, Yan Z, Yang W, Zhai D, Wang L, Ye Z, Lu H, Xiang A, Liang J, et al. Retraction Note: Azoramide, a novel regulator, favors adipogenesis against osteogenesis through inhibiting the GLP-1 receptor-PKA-β-catenin pathway. Stem Cell Res Ther. 2023;14(1):275.
Yang W, Xu M, Xu S, Guan Q, Geng S, Wang J, Wei W, Xu H, Liu Y, Meng Y, et al. Single-cell RNA reveals a tumorigenic microenvironment in the interface zone of human breast tumors. Breast Cancer Res. 2023;25(1):100.
Zhang X, Gale RPeter, Liu B, Huang J, Zhang Y, Du X, Weng J, Li W, Xu N, Liu X, et al. Validation of the imatinib-therapy failure model. Leukemia. 2023.

Pages